Stimulatory effect of increased non-esterified fatty acid concentrations on proinsulin processing in healthy humans

Diabetologia

Volumn 43, Issue 11, 2000, Pages 1368-1373

  Stefan, N ^a   Fritsche, A ^a   Madaus, A ^a   Haring, H ^a   Stumvoll, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Arginine; Glucose; Insulin secretion; Non esterified fatty acids; Proinsulin secretion

Indexed keywords

ARGININE; FATTY ACID; HEPARIN; INSULIN; INTRALIPID; PROINSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; ARGININE; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; PROINSULIN;

EID: 0033753234     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051540     Document Type: Article

References (26)

1. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
2. Fatty acids, lipotoxicity and insulin secretion
3. Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes
4. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects
5. Effects of a 48-h fat infusion on insulin secretion and glucose utilization
6. What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism
7. Metabolism of endogenous proinsulin and insulin in man
8. Effect of insulin resistance and hyperglycaemia on proinsulin release in a primate model of diabetes mellitus
9. Disproportionate elevation of immunoreactive proinsulin in Type II (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance
10. A sensitive radioimmunoassay for human proinsulin, with sequential use of antisera to C-peptide and insulin
11. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance
12. Disproportionate elevation of immunoreactive proinsulin in Type II (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance
13. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
14. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus
15. Hyperproinsulinaemia in impaired glucose tolerance
16. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets
17. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance
18. Prehepatic insulin production in man: Kinetic analysis using peripheral connecting peptide behavior
19. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6
20. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation
21. Effect of fatty acids on insulin release: Role of chain length and degree of unsaturation
22. Glucose-induced preproinsulin gene expression is inhibited by the free fatty acid palmitate
23. Differential effects of cis and trans fatty acids on insulin release from isolated mouse islets
24. Chronic exposure to free fatty acids reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation
25. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion
26. Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose